Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinoma (CSCC) is the second most common skin cancer diagnosed worldwide. CSCC is generally localized and managed with local therapies such as excision and/or radiotherapy. For patients with unresectable or metastatic disease, recent improvements in our understanding of the...
Guardado en:
Autores principales: | Alesha A. Thai, Annette M. Lim, Benjamin J. Solomon, Danny Rischin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d012c34f6fe8455b9f888836410ccca0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma
por: Nader Aboul-Fettouh, et al.
Publicado: (2021) -
Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
por: Jacob D. Siegel, MD, et al.
Publicado: (2021) -
Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy
por: Sabino Strippoli, et al.
Publicado: (2021) -
Risk Factors and Diagnosis of Advanced Cutaneous Squamous Cell Carcinoma
por: Gabriella Brancaccio, et al.
Publicado: (2021) -
Cutaneous horns: clues to invasive squamous cell carcinoma being present in the horn base
por: John Pyne, et al.
Publicado: (2013)